cryptocurrency owned by banks searches

The three departments issued the tax policy on the transformation of operating cultural institutions into enterprises in the cultural system reform, and the Ministry of Finance, the State Administration of Taxation and the Central Propaganda Department issued the Announcement on the Tax Policy on the Transformation of Operating Cultural Institutions into Enterprises in the Cultural System Reform, which mentioned that operating cultural institutions can enjoy the following transitional tax preferential policies: if operating cultural institutions are transformed into enterprises before December 31, 2022, they will be exempted from enterprise income tax from the date of registration of transformation to December 31, 2027. If a cultural unit funded by the financial department is transformed into an enterprise before December 31, 2022, its self-use property will be exempted from property tax from the date of registration of transformation to December 31, 2027.Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.

Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%. Yonhap News Agency: South Korean police special investigation team raided the presidential palace on martial law.

Ukraine claimed to attack an oil facility being used by the Russian army. On December 11, local time, the General Staff of the Ukrainian army released a message that the joint intelligence department of the Ukrainian army attacked an oil facility being used by the Russian army in Bryansk State, Russia, in the early morning of December 11. The facility caught fire after being attacked and has stopped working. The Russian side has not responded to this for the time being. (CCTV News)Gold prices rose three times in a row, and brands such as Chow Tai Fook and Lao Fengxiang broke through 810 yuan. After a short-term shock, the gold trend became stronger. On December 11th, spot gold hit $2,700 per ounce, hitting a two-week high and rising for three consecutive days. As of press time, COMEX Gold reported $2,737.5 per ounce, up 0.7% in the day. In the domestic gold consumption market, the gold prices of gold brands such as Chow Tai Fook, Lao Fengxiang and Luk Fook Jewelry reached 812 yuan/gram, while the gold prices in Zhou Shengsheng reached 814 yuan/gram. (Dahe Finance Cube)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.